Search

everythinglearnresearchcommunity

for

Search:↓

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Runners often face skin problems like blisters and infections, and both prevention and early treatment are important.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Fever and rash can be early signs of lupus.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Some drugs may help treat both COVID-19 and radiation injury.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

COVID-19 infection may trigger alopecia areata in some patients.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 can cause significant hair loss.

COVID-19 can cause hair loss, but specialists can help treat it.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Athletes can experience various skin issues, which can be treated and prevented with appropriate care and protective measures.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

A woman with lupus and severe nerve damage improved with specific treatments.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.